294 related articles for article (PubMed ID: 28112438)
1. Protein kinase C in cancer: The top five unanswered questions.
Cooke M; Magimaidas A; Casado-Medrano V; Kazanietz MG
Mol Carcinog; 2017 Jun; 56(6):1531-1542. PubMed ID: 28112438
[TBL] [Abstract][Full Text] [Related]
2. New insights into the regulation of protein kinase C and novel phorbol ester receptors.
Ron D; Kazanietz MG
FASEB J; 1999 Oct; 13(13):1658-76. PubMed ID: 10506570
[TBL] [Abstract][Full Text] [Related]
3. Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters.
Brose N; Rosenmund C
J Cell Sci; 2002 Dec; 115(Pt 23):4399-411. PubMed ID: 12414987
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of the receptors for the phorbol ester tumor promoters: multiple receptors with different biochemical properties.
Kazanietz MG; Caloca MJ; Eroles P; Fujii T; García-Bermejo ML; Reilly M; Wang H
Biochem Pharmacol; 2000 Nov; 60(10):1417-24. PubMed ID: 11020443
[TBL] [Abstract][Full Text] [Related]
5. Targeting protein kinase C and "non-kinase" phorbol ester receptors: emerging concepts and therapeutic implications.
Kazanietz MG
Biochim Biophys Acta; 2005 Dec; 1754(1-2):296-304. PubMed ID: 16202672
[TBL] [Abstract][Full Text] [Related]
6. Differential Regulation of Gene Expression in Lung Cancer Cells by Diacyglycerol-Lactones and a Phorbol Ester Via Selective Activation of Protein Kinase C Isozymes.
Cooke M; Casado-Medrano V; Ann J; Lee J; Blumberg PM; Abba MC; Kazanietz MG
Sci Rep; 2019 Apr; 9(1):6041. PubMed ID: 30988374
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C and other diacylglycerol effectors in cancer.
Griner EM; Kazanietz MG
Nat Rev Cancer; 2007 Apr; 7(4):281-94. PubMed ID: 17384583
[TBL] [Abstract][Full Text] [Related]
8. Divergence and complexities in DAG signaling: looking beyond PKC.
Yang C; Kazanietz MG
Trends Pharmacol Sci; 2003 Nov; 24(11):602-8. PubMed ID: 14607084
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C: perfectly balanced.
Newton AC
Crit Rev Biochem Mol Biol; 2018 Apr; 53(2):208-230. PubMed ID: 29513138
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression.
Isakov N
Semin Cancer Biol; 2018 Feb; 48():36-52. PubMed ID: 28571764
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C and cancer: what we know and what we do not.
Garg R; Benedetti LG; Abera MB; Wang H; Abba M; Kazanietz MG
Oncogene; 2014 Nov; 33(45):5225-37. PubMed ID: 24336328
[TBL] [Abstract][Full Text] [Related]
12. The pros and cons of targeting protein kinase C (PKC) in the management of cancer patients.
Leskow FC; Krasnapolski MA; Urtreger AJ
Curr Pharm Biotechnol; 2011 Nov; 12(11):1961-73. PubMed ID: 21470133
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C isoenzymes display differential affinity for phorbol esters. Analysis of phorbol ester receptors in B cell differentiation.
Marquez C; Martinez C; Kroemer G; Bosca L
J Immunol; 1992 Oct; 149(8):2560-8. PubMed ID: 1401894
[TBL] [Abstract][Full Text] [Related]
14. Fumonisin B1 induces protein kinase C translocation via direct interaction with diacylglycerol binding site.
Yeung JM; Wang HY; Prelusky DB
Toxicol Appl Pharmacol; 1996 Nov; 141(1):178-84. PubMed ID: 8917690
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic role of targeting protein kinase C in solid and hematologic malignancies.
Podar K; Raab MS; Chauhan D; Anderson KC
Expert Opin Investig Drugs; 2007 Oct; 16(10):1693-707. PubMed ID: 17922632
[TBL] [Abstract][Full Text] [Related]
16. Toward the development of new medicinal leads with selectivity for protein kinase C isozymes.
Irie K; Nakagawa Y; Ohigashi H
Chem Rec; 2005; 5(4):185-95. PubMed ID: 16041745
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin and angiotensin II: activation of protein kinase C in arterial smooth muscle.
Dixon BS; Sharma RV; Dickerson T; Fortune J
Am J Physiol; 1994 May; 266(5 Pt 1):C1406-20. PubMed ID: 8203504
[TBL] [Abstract][Full Text] [Related]
18. PKD at the crossroads of DAG and PKC signaling.
Wang QJ
Trends Pharmacol Sci; 2006 Jun; 27(6):317-23. PubMed ID: 16678913
[TBL] [Abstract][Full Text] [Related]
19. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes.
Bandyopadhyay G; Standaert ML; Galloway L; Moscat J; Farese RV
Endocrinology; 1997 Nov; 138(11):4721-31. PubMed ID: 9348199
[TBL] [Abstract][Full Text] [Related]
20. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells.
Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A
Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
